Key findings from the 2021 Swiss study:
Over the next two years, 70% of all respondents confirm they will outsource at the same rate or more, with 40% citing that they are planning to outsource more. Insourcing plans remain stable with one in five organisations planning to outsource less. This is currently the highest level in Europe where this study is conducted. For the second year in a row the number one factor for organisations intending to insource is faster time to market and improved quality outcomes.
By industry, the life science and pharmaceuticals sector are planning to increase their outsourcing the most in the next two years (48%) while only 10% will outsource less (half the overall average for Switzerland). In contrast, only 30% of manufacturing and chemicals organisations are planning to increase their level of outsourcing, while more than half (52%) say there will be no change. The financial services sector has the highest percentage of participants planning to insource with 32% (up 7% from 2020 and 14% overall since 2019).